Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 5/2021

21.01.2021 | Original Paper

Cardiac MRI assessment of the right ventricle pre-and post-kidney transplant

verfasst von: Abdulaziz Ahmed Hashi, G. V. Ramesh Prasad, Philip W. Connelly, Djeven P. Deva, Michelle M. Nash, Weiqiu Yuan, Rachel M. Wald, Ron Wald, Lakshman Gunaratnam, Charmaine E. Lok, S. Joseph Kim, Gauri R. Karur, Kim A. Connelly, Andrew T. Yan

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Abstract

Worsening renal function in chronic kidney disease correlates with worsening right ventricular (RV) systolic function. We evaluated the association between kidney transplantation (KT) and RV structure and systolic function, and the relationships between RV and left ventricular (LV) changes, blood pressure, and specific cardiac biomarkers, in patients with end-stage kidney disease using cardiac magnetic resonance imaging (CMR). In this prospective, multi-centre, cohort study, 39 adult patients on dialysis receiving KT and 42 patients eligible for, but not yet receiving KT, were recruited. CMR was performed at baseline, and repeated at 12 months. Among 81 patients (mean age 51 years, 30% female), RV end-diastolic volume index (RVEDVi), end-systolic volume index (RVESVi), mass index (RVMi), and ejection fraction (RVEF) did not change significantly within either the dialysis or KT group over 12 months (all p ≥ 0.10). There were no significant differences in the 12-month changes of these parameters between the dialysis and KT groups (all p ≥ 0.10). RVMI demonstrated positive correlations with NT-proBNP and systolic blood pressure, but not GDF-15, at baseline and at 12 months. Changes in RVEDVi, RVESVi, and RVEF were positively correlated with changes in LVEDVi, LVESVi, and LVEF, respectively over 12 months (Spearman r = 0.72, 0.52, and 0.41; all p < 0.001), but not mass index (Spearman r = 0.20, p = 0.078). In conclusion, there were no significant changes in RV mass, volumes, or systolic function 12 months after KT, as compared with continuation of dialysis. The associations between RV and LV remodeling may suggest similar underlying pathophysiologic mechanisms.
Literatur
1.
Zurück zum Zitat Arora P, Vasa P, Brenner D, Iglar K, McFarlane P, Morrison H, Badawi A (2013) Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. CMAJ 185(9):417–423CrossRef Arora P, Vasa P, Brenner D, Iglar K, McFarlane P, Morrison H, Badawi A (2013) Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. CMAJ 185(9):417–423CrossRef
2.
Zurück zum Zitat Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Inter Suppl 3:1–150CrossRef Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Inter Suppl 3:1–150CrossRef
3.
Zurück zum Zitat Shamseddin MK, Parfrey PS (2010) Sudden cardiac death in chronic kidney disease: epidemiology and prevention. Nat Rev Nephrol 7(3):145–154CrossRef Shamseddin MK, Parfrey PS (2010) Sudden cardiac death in chronic kidney disease: epidemiology and prevention. Nat Rev Nephrol 7(3):145–154CrossRef
4.
Zurück zum Zitat Collins AJ, Foley RN, Herzog C, Chavers BM, Gilbertson D, Ishani A, Kasiske BL, Liu J, Mau LW, McBean M, Murray A, St Peter W, Guo H, Li Q, Li S, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, Solid C, Wang C, Weinhandl E, Zaun D, Arko C, Chen SC, Dalleska F, Daniels F, Dunning S, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers PW, Agodoa L (2010) Excerpts from the US renal data system 2009 annual data report. Am J Kidney Dis 55(1 Suppl 1):S1–S420PubMedPubMedCentral Collins AJ, Foley RN, Herzog C, Chavers BM, Gilbertson D, Ishani A, Kasiske BL, Liu J, Mau LW, McBean M, Murray A, St Peter W, Guo H, Li Q, Li S, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, Solid C, Wang C, Weinhandl E, Zaun D, Arko C, Chen SC, Dalleska F, Daniels F, Dunning S, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers PW, Agodoa L (2010) Excerpts from the US renal data system 2009 annual data report. Am J Kidney Dis 55(1 Suppl 1):S1–S420PubMedPubMedCentral
5.
Zurück zum Zitat Meier-Kriesche H, Schold JD, Kaplan B (2005) Preservation of long-term renal allograft survival: a challenge for the years to come. Am J Transplant 5(3):632–633CrossRef Meier-Kriesche H, Schold JD, Kaplan B (2005) Preservation of long-term renal allograft survival: a challenge for the years to come. Am J Transplant 5(3):632–633CrossRef
6.
Zurück zum Zitat Ojo AO, Hanson JA, Wolfe RA, Leichtman AB, Agodoa LY, Port FK (2000) Long-term survival in renal transplant recipients with graft function. Kidney Int 57(1):307–313CrossRef Ojo AO, Hanson JA, Wolfe RA, Leichtman AB, Agodoa LY, Port FK (2000) Long-term survival in renal transplant recipients with graft function. Kidney Int 57(1):307–313CrossRef
7.
Zurück zum Zitat Schiffrin EL, Lipman ML, Mann JFE (2007) Chronic kidney disease effects on the cardiovascular system. Circulation 116(1):85–97CrossRef Schiffrin EL, Lipman ML, Mann JFE (2007) Chronic kidney disease effects on the cardiovascular system. Circulation 116(1):85–97CrossRef
8.
Zurück zum Zitat Ronco C, Haapio M, House AA, Anavekar N, Bellomo R (2008) Cardiorenal syndrome. J Am Coll Cardiol 52(19):1527–1539CrossRef Ronco C, Haapio M, House AA, Anavekar N, Bellomo R (2008) Cardiorenal syndrome. J Am Coll Cardiol 52(19):1527–1539CrossRef
9.
Zurück zum Zitat Di Lullo L, Gorini A, Russo D, Santoboni A, Ronco C (2015) Left ventricular hypertrophy in chronic kidney disease patients: from pathophysiology to treatment. Cardiorenal Med 5(4):254–266CrossRef Di Lullo L, Gorini A, Russo D, Santoboni A, Ronco C (2015) Left ventricular hypertrophy in chronic kidney disease patients: from pathophysiology to treatment. Cardiorenal Med 5(4):254–266CrossRef
10.
Zurück zum Zitat Palazzuoli A, Beltrami M, Nodari S, McCollough PA, Ronco C (2011) Clinical impact of renal dysfunction in heart failure. Rev Cardiovasc Med 12(4):186–199PubMed Palazzuoli A, Beltrami M, Nodari S, McCollough PA, Ronco C (2011) Clinical impact of renal dysfunction in heart failure. Rev Cardiovasc Med 12(4):186–199PubMed
11.
Zurück zum Zitat Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE (1996) Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 11(7):1277–1285CrossRef Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE (1996) Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 11(7):1277–1285CrossRef
12.
Zurück zum Zitat Dini FL, Ryan TD, Simioniuc A, Morrone D, Donati F, Guarini G, Orsini E, Caravelli P, Marzilli M, Colombo PC (2012) Right ventricular dysfunction is associated with chronic kidney disease and predicts survival in patients with chronic systolic heart failure. Eur J Heart Fail 14(3):287–294CrossRef Dini FL, Ryan TD, Simioniuc A, Morrone D, Donati F, Guarini G, Orsini E, Caravelli P, Marzilli M, Colombo PC (2012) Right ventricular dysfunction is associated with chronic kidney disease and predicts survival in patients with chronic systolic heart failure. Eur J Heart Fail 14(3):287–294CrossRef
13.
Zurück zum Zitat Bozbas SS, Kanyilmaz S, Akcay S, Bozbas H, Altin C, Karacaglar E, Muderrisoglu H, Haberal M (2011) Renal transplant improves pulmonary hypertension in patients with end stage renal disease. Multidiscip Respir Med 6(3):155–160CrossRef Bozbas SS, Kanyilmaz S, Akcay S, Bozbas H, Altin C, Karacaglar E, Muderrisoglu H, Haberal M (2011) Renal transplant improves pulmonary hypertension in patients with end stage renal disease. Multidiscip Respir Med 6(3):155–160CrossRef
14.
Zurück zum Zitat von Knobelsdorff-Brenkenhoff, Tkachenko V, Winter L, Rieger J, Thalhammer C, Hezel F, Graessl A, Dieringer MA, Niendorf T, Schulz-Menger J (2013) Assessment of the right ventricle with cardiovascular magnetic resonance at 7 T. J Cardiovasc Magn Reson 15(23):1–9 von Knobelsdorff-Brenkenhoff, Tkachenko V, Winter L, Rieger J, Thalhammer C, Hezel F, Graessl A, Dieringer MA, Niendorf T, Schulz-Menger J (2013) Assessment of the right ventricle with cardiovascular magnetic resonance at 7 T. J Cardiovasc Magn Reson 15(23):1–9
15.
Zurück zum Zitat Fent G, Plein S (2016) New cardiac magnetic resonance reference ranges for right ventricular volumes and systolic function. Circ Cardiovasc Imaging 9:e004589CrossRef Fent G, Plein S (2016) New cardiac magnetic resonance reference ranges for right ventricular volumes and systolic function. Circ Cardiovasc Imaging 9:e004589CrossRef
16.
Zurück zum Zitat Gong IY, Al-Amro B, Ramesh Prasad GV, Connelly PW, Wald RM, Wald R, Deva DP, Leong-Poi H, Nash MM, Yuan W, Gunaratanam L, Kim SJ, Lok CE, Connelly KA, Yan AT (2018) Cardiovascular magnetic resonance left ventricular strain in end-stage renal disease patients after kidney transplantation. J Cardiovasc Magn Reson 20(83):1–11 Gong IY, Al-Amro B, Ramesh Prasad GV, Connelly PW, Wald RM, Wald R, Deva DP, Leong-Poi H, Nash MM, Yuan W, Gunaratanam L, Kim SJ, Lok CE, Connelly KA, Yan AT (2018) Cardiovascular magnetic resonance left ventricular strain in end-stage renal disease patients after kidney transplantation. J Cardiovasc Magn Reson 20(83):1–11
17.
Zurück zum Zitat Prasad GVR, Yan AT, Nash MM, Kim SJ, Wald R, Wald R, Lok C, Gunaratanam L, Karur GR, Kirpalani A, Connelly PW (2018) Determinants of left ventricular characteristics assessed by cardiac magnetic resonance imaging and cardiovascular biomarkers related to kidney transplantation. Can J Kidney Health Dis 5:1–13CrossRef Prasad GVR, Yan AT, Nash MM, Kim SJ, Wald R, Wald R, Lok C, Gunaratanam L, Karur GR, Kirpalani A, Connelly PW (2018) Determinants of left ventricular characteristics assessed by cardiac magnetic resonance imaging and cardiovascular biomarkers related to kidney transplantation. Can J Kidney Health Dis 5:1–13CrossRef
18.
Zurück zum Zitat Wollert KC, Kempf T, Wallentin L (2017) Growth differentiation factor 15 as a biomarker in cardiovascular disease. Clin Chem 63(1):140–151CrossRef Wollert KC, Kempf T, Wallentin L (2017) Growth differentiation factor 15 as a biomarker in cardiovascular disease. Clin Chem 63(1):140–151CrossRef
19.
Zurück zum Zitat Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ (2005) Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans. Circulation 111(5):697–716CrossRef Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ (2005) Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans. Circulation 111(5):697–716CrossRef
20.
Zurück zum Zitat Kawel-Boehm N, Maceira A, Valsangiacomo-Buechel ER, Vogel-Claussen J, Turkbey EV, Williams R, Plein S, Tee M, Eng J, Bluemke DA (2015) Normal values for cardiovascular magnetic resonance in adults and children. J Cardiovasc Magn Reson 17(29):1–33 Kawel-Boehm N, Maceira A, Valsangiacomo-Buechel ER, Vogel-Claussen J, Turkbey EV, Williams R, Plein S, Tee M, Eng J, Bluemke DA (2015) Normal values for cardiovascular magnetic resonance in adults and children. J Cardiovasc Magn Reson 17(29):1–33
21.
Zurück zum Zitat Hewing B, Dehn AM, Staeck O, Knebel F, Spethmann S, Stangl K, Baumann G, Dreger H, Budde K, Halleck F (2016) Improved left ventricular structure and function after successful kidney transplantation. Kidney Blood Press Res 41(5):701–709CrossRef Hewing B, Dehn AM, Staeck O, Knebel F, Spethmann S, Stangl K, Baumann G, Dreger H, Budde K, Halleck F (2016) Improved left ventricular structure and function after successful kidney transplantation. Kidney Blood Press Res 41(5):701–709CrossRef
22.
Zurück zum Zitat Garcia-Covarrubias L, Hernandez K, Castro I, Hinojosa H, Molina L, Bazan O, Gutierrez C, Reding-Bernal A, Barragan J, Garcia A, Fernandez D, Fragoso P, Torres JM, Ortuno D, Prieto P, Diliz H (2018) Cardiac remodeling in structure and function six months after kidney transplantation. Transplant Proc 50(2):454–457CrossRef Garcia-Covarrubias L, Hernandez K, Castro I, Hinojosa H, Molina L, Bazan O, Gutierrez C, Reding-Bernal A, Barragan J, Garcia A, Fernandez D, Fragoso P, Torres JM, Ortuno D, Prieto P, Diliz H (2018) Cardiac remodeling in structure and function six months after kidney transplantation. Transplant Proc 50(2):454–457CrossRef
23.
Zurück zum Zitat Patel RJ, Mark PB, Johnston N, McGregor E, Dargie HJ, Jardine AG (2008) Renal transplantation is not associated with regression of left ventricular hypertrophy: A magnetic resonance study. Clin J Am Soc Nephro 3(6):1807–1811CrossRef Patel RJ, Mark PB, Johnston N, McGregor E, Dargie HJ, Jardine AG (2008) Renal transplantation is not associated with regression of left ventricular hypertrophy: A magnetic resonance study. Clin J Am Soc Nephro 3(6):1807–1811CrossRef
24.
Zurück zum Zitat Karur GR, Wald R, Goldstein M, Wald R, Jimenez-Juan L, Kiaii M, Leipsic J, Kirpalani A, Bello O, Barthur A, Ng MY, Deva DP, Yan AT (2017) Association between conversion to in-center nocturnal hemodialysis and right ventricular remodeling. Nephrol Dial Transplant 33(6):1010–1016CrossRef Karur GR, Wald R, Goldstein M, Wald R, Jimenez-Juan L, Kiaii M, Leipsic J, Kirpalani A, Bello O, Barthur A, Ng MY, Deva DP, Yan AT (2017) Association between conversion to in-center nocturnal hemodialysis and right ventricular remodeling. Nephrol Dial Transplant 33(6):1010–1016CrossRef
25.
Zurück zum Zitat Dumaine RL, Montalescot G, Steg PG, Ohman EM, Eagle K, Bhatt DL (2009) Renal function, atherothrombosis extent, and outcomes in high-risk patients. Am Heart J 158(1):141–148CrossRef Dumaine RL, Montalescot G, Steg PG, Ohman EM, Eagle K, Bhatt DL (2009) Renal function, atherothrombosis extent, and outcomes in high-risk patients. Am Heart J 158(1):141–148CrossRef
26.
Zurück zum Zitat Wald R, Goldstein MB, Perl J, Kiaii M, Yuen D, Wald RM, Harel Z, Weinstein JJ, Jakubovic B, Leong-Poi H, Kirpalani A, Leipsic J, Dacouris N, Wolf M, Yan AT (2016) The association between conversion to in-centre nocturnal hemodialysis and left ventricular mass regression in patients with end-stage renal disease. Can J Card 32(3):1–9 Wald R, Goldstein MB, Perl J, Kiaii M, Yuen D, Wald RM, Harel Z, Weinstein JJ, Jakubovic B, Leong-Poi H, Kirpalani A, Leipsic J, Dacouris N, Wolf M, Yan AT (2016) The association between conversion to in-centre nocturnal hemodialysis and left ventricular mass regression in patients with end-stage renal disease. Can J Card 32(3):1–9
27.
Zurück zum Zitat Paneni F, Gregori M, Ciavarella G, Sciarretta S, De Biase L, Marino L, Tocci G, Principe F, Domenici A, Luciani R, Punzo G, Mene P, Volpe M (2010) Right ventricular dysfunction in patients with end-stage renal disease. Am J Nephrol 32(5):432–438CrossRef Paneni F, Gregori M, Ciavarella G, Sciarretta S, De Biase L, Marino L, Tocci G, Principe F, Domenici A, Luciani R, Punzo G, Mene P, Volpe M (2010) Right ventricular dysfunction in patients with end-stage renal disease. Am J Nephrol 32(5):432–438CrossRef
28.
Zurück zum Zitat Glassock RJ, Pecoits-Filho R, Barberato SH (2009) Left ventricular mass in chronic kidney disease and ESRD. Clin J Am Soc Nephrol 4(Suppl(1):S79–S91CrossRef Glassock RJ, Pecoits-Filho R, Barberato SH (2009) Left ventricular mass in chronic kidney disease and ESRD. Clin J Am Soc Nephrol 4(Suppl(1):S79–S91CrossRef
29.
Zurück zum Zitat Palazzuoli A, Gallotta M, Quatrini I, Nuti R (2010) Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure. Vasc Health Risk Manag 6:411–418CrossRef Palazzuoli A, Gallotta M, Quatrini I, Nuti R (2010) Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure. Vasc Health Risk Manag 6:411–418CrossRef
30.
Zurück zum Zitat Blyth KG, Groenning BA, Mark PB, Martin TN, Forster JE, Steedman T, Morton JJ, Dargie HJ, Peacock AJ (2007) NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension. Eur Respir J 29(4):737–744CrossRef Blyth KG, Groenning BA, Mark PB, Martin TN, Forster JE, Steedman T, Morton JJ, Dargie HJ, Peacock AJ (2007) NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension. Eur Respir J 29(4):737–744CrossRef
Metadaten
Titel
Cardiac MRI assessment of the right ventricle pre-and post-kidney transplant
verfasst von
Abdulaziz Ahmed Hashi
G. V. Ramesh Prasad
Philip W. Connelly
Djeven P. Deva
Michelle M. Nash
Weiqiu Yuan
Rachel M. Wald
Ron Wald
Lakshman Gunaratnam
Charmaine E. Lok
S. Joseph Kim
Gauri R. Karur
Kim A. Connelly
Andrew T. Yan
Publikationsdatum
21.01.2021
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 5/2021
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-020-02153-4

Weitere Artikel der Ausgabe 5/2021

The International Journal of Cardiovascular Imaging 5/2021 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.